ArticleNoro psikiyatri arsivi2026
Clinical and Electrophysiological Characteristics of Guillain-Barré Syndrome Across Pre-Pandemic, Pandemic, and Post-Pandemic Periods: A Ten-Year Retrospective Cohort Study.
Article in Noro psikiyatri arsivi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The COVID-19 pandemic markedly altered patterns of exposure to respiratory and gastrointestinal pathogens, healthcare-seeking behaviors, and environmental immune triggers. Guillain-Barré syndrome (GBS), an immune-mediated polyradiculoneuropathy frequently preceded by an infectious event, may therefore exhibit changes in clinical presentation or electrophysiologic subtype distribution. However, it remains unclear whether the clinical and electrophysiological characteristics of GBS have changed across pandemic periods. Methods: This retrospective cohort included adults diagnosed with GBS between March 2015 and October 2025 at a tertiary referral center. Patients were grouped into pre-pandemic, pandemic, and post-pandemic periods. Clinical features, antecedent events, severity scores, and electrophysiologic subtypes (classified using Uncini criteria) were compared. Group comparisons were performed using chi-square, Fisher's exact test, and non-parametric tests where appropriate. Results: Seventy patients were included: 31 pre-pandemic, 24 during the pandemic, and 15 post-pandemic. Age, sex, CSF findings, clinical and electrophysiological subtype distribution were similar across groups. Sensory and motor symptom subcategories and deep tendon reflexes did not differ. Antecedent event types differed significantly across periods (p=0.015). Admission Hughes score, MRC sum score, and mEGRIS score showed significant differences, indicating more severe presentation in the pre-pandemic group. Post-hoc comparisons suggested that these differences were primarily driven by comparisons between pre- and post-pandemic groups. Conclusion: Despite pandemic-related epidemiological changes, the fundamental clinical and electrophysiological characteristics of GBS remained stable. However, differences in initial disease severity may reflect changes in environmental exposures and healthcare-seeking behavior rather than intrinsic alterations in disease pathophysiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.